News

Allen & Overy advises Dr. Max on the financing for the acquisition of Neo Apotek

Published Date
Jan 11 2024
Following the completion of the acquisition of Neo Apotek by Dr. Max Group, one of the most important operators specialising in the management of pharmacies in Europe, the agreements relating to the reimbursement, remodulation and provision of new finance in favour of Neo Apotek and some of its subsidiaries have been finalized.

Allen & Overy advised Dr. Max on the transaction in relation to all financial aspects preliminary and functional to the completion and implementation of the acquisition, including the repayment of part of the existing debt of NeoApotek and its subsidiaries, the remodeling of the remaining part and the obtaining of new finance for the group.

The A&O team was led by partner Stefano Sennhauser, supported by associate Valentina Calò and trainee Alessia Cellucci. 

Content Disclaimer

This content was originally published by Allen & Overy before the A&O Shearman merger

Related capabilities